Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
James Neal Insider Profile
4 Followers
James Neal, CEO, Director at Xoma, holds 32.22M shares in Akari Therapeutics (Ticker: AKTX), holds 0.00 shares in Peak Bio (Ticker: PKBO), holds 10.92K shares in Palisade Bio (Ticker: PALI).
Profitable Transactions
13 out of 14 Profitable Transactions
Average Return
+52.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that James Neal holds in companies
Most Profitable Insider Trade
The most profitable trade made by James Neal
James Neal's Trading History
Xoma
Jul 18, 2022
CEO, Director
Uninformative Buy
100.75K
$893.30K
Palisade Bio
Feb 13, 2024
Director
Uninformative Buy
4.80K
$16.16K
Processa Pharmaceuticals
Jul 24, 2023
Director
Uninformative Buy
7.38K
$11.64K
Peak Bio
Nov 18, 2024
―
Uninformative Buy
―
$0.00
Akari Therapeutics
Jan 10, 2025
Director
Uninformative Buy
―
$38.30M
List of latest transactions for each holding click on a transaction to see James Neal's performance on stock
You May Also Like
James Neal insider profile FAQ
What is the percentage of profitable transactions made by James Neal?
The percentage of profitable transactions made by James Neal is 93%.
What is the average return per transaction made by James Neal?
The average return per transaction made by James Neal is 52.70%.
What stocks does James Neal hold?
James Neal holds: XOMA, PALI, PCSA, PKBO, AKTX stocks.
What was James Neal’s latest transaction?
James Neal latest transaction was an Uninformative Buy of ―.
What was James Neal's most profitable transaction?
James Neal’s most profitable transaction was an Informative Buy of XOMA stock on December 21, 2018. The return on the trade was 116.00%.
What is James Neal's role in Xoma?
James Neal's role in Xoma is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.